Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price51.42 USD
Fair value41.95
Our investment reviews on this name
2026-08-29Read Markup44.05+16.7% to today ✓
2026-07-02Read Accumulation35.17+46.2% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Frontline plc holds its Markup at $51.42. The statistical read favours the buyers, held for 5 days.
As held on the ledger · 2026-09-18
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 5 days
Price at the screen
$51.42
Valuation
7.71 trailing · 11.47 forward price to earnings
Values screen
FAIL
Beta
0.06
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
37.15%
Below 33%
Interest-bearing debt is 37.2% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
3.07%
Below 33%
Cash held in interest-bearing accounts and securities is 3.1% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-18 screen. The gold marker is the market price at the same screen. The price runs 18.4% above the base estimate.
Third-party analyst targets: 4 covering, consensus Buy. The average target sits −11% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-18 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Tanker profits look tempting at peak cycle
Oil moves across oceans in fleets that earn fortunes when energy prices spike and then watch those same earnings collapse when demand cools. Frontline sits right in that flow, posting 67% revenue growth and a 40% profit margin with 35% return on equity. The forward multiple of 10.3 times earnings appears cheap next to those figures and a moderate moat, yet the shares trade almost exactly at our fair value with almost no margin of safety.
Those headline numbers reflect conditions at the top of the cycle rather than a durable edge. Four analysts see a median target of $42, but the business remains exposed to freight rate swings that have crushed similar operators in past downturns. Low multiples on peak earnings have often proved a warning sign, not a bargain, in this industry.
The ethical screen also flags the debt ratio, ruling the name out regardless of the near-term cash flow. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FRO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-29Markup · changed$44.05+20.7%Entry 5
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 20.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 114%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (4 analysts) rates it buy, with a mean price target of $42.
2026-07-30Accumulation$36.49+3.8%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 114%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (4 analysts) rates it buy, with a mean price target of $42.
2026-07-18Accumulation$35.17+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 114%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (4 analysts) rates it buy, with a mean price target of $42.
2026-07-03Accumulation$35.17+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Accumulation$35.17Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.